Alpha Tau Medical (DRTS) News Today

Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) saw a large increase in short interest during the month of August. As of August 31st, there was short interest totalling 33,000 shares, an increase of 63.4% from the August 15th total of 20,200 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 33,200 shares, the short-interest ratio is presently 1.0 days.

Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Research analysts at HC Wainwright reduced their FY2024 EPS estimates for shares of Alpha Tau Medical in a report issued on Tuesday, August 20th. HC Wainwright analyst Y. Chen now forecasts that the company will earn ($0.47) per share for the y

HC Wainwright reaffirmed a "buy" rating and issued a $9.00 target price on shares of Alpha Tau Medical in a research report on Tuesday.

Piper Sandler reiterated an "overweight" rating and set a $7.00 price target on shares of Alpha Tau Medical in a research report on Thursday.

Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the recipient of a significant growth in short interest in June. As of June 30th, there was short interest totalling 28,300 shares, a growth of 60.8% from the June 15th total of 17,600 shares. Based on an average daily volume of 41,300 shares, the days-to-cover ratio is currently 0.7 days. Approximately 0.1% of the shares of the stock are sold short.

Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) saw a large decline in short interest in May. As of May 15th, there was short interest totalling 26,900 shares, a decline of 6.9% from the April 30th total of 28,900 shares. Approximately 0.1% of the company's stock are sold short. Based on an average trading volume of 34,800 shares, the short-interest ratio is currently 0.8 days.

Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Research analysts at HC Wainwright raised their FY2024 earnings estimates for shares of Alpha Tau Medical in a research note issued on Wednesday, May 22nd. HC Wainwright analyst Y. Chen now forecasts that the company will post earnings per shar

Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Equities research analysts at HC Wainwright issued their Q2 2025 earnings per share estimates for shares of Alpha Tau Medical in a research report issued on Wednesday, May 22nd. HC Wainwright analyst Y. Chen anticipates that the company will po

HC Wainwright reissued a "buy" rating and issued a $9.00 price target on shares of Alpha Tau Medical in a report on Wednesday.

Alpha Tau Medical (NASDAQ:DRTS - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.13) by $0.02.

HC Wainwright reissued a "buy" rating and issued a $9.00 price target on shares of Alpha Tau Medical in a research note on Thursday.

Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the recipient of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 34,900 shares, a growth of 22.5% from the February 29th total of 28,500 shares. Approximately 0.1% of the company's stock are short sold. Based on an average daily volume of 34,500 shares, the days-to-cover ratio is currently 1.0 days.

Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Equities researchers at HC Wainwright lifted their FY2024 earnings per share estimates for shares of Alpha Tau Medical in a research report issued on Tuesday, March 12th. HC Wainwright analyst Y. Chen now expects that the company will post earn

Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the target of a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 73,500 shares, a growth of 12.9% from the November 15th total of 65,100 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average trading volume of 25,700 shares, the days-to-cover ratio is presently 2.9 days.

Citigroup assumed coverage on shares of Alpha Tau Medical in a report on Friday. They issued a "buy" rating and a $8.00 target price on the stock.

Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Equities researchers at Cantor Fitzgerald upped their FY2023 earnings estimates for Alpha Tau Medical in a note issued to investors on Tuesday, August 29th. Cantor Fitzgerald analyst K. Kluska now anticipates that the company will post earnings

ProVise Management Group LLC purchased a new stake in Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 35,070 shares of the company's stock, valued at approxima

ETF Managers Group LLC bought a new stake in Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 66,326 shares of the company's stock, valued at approximately $

Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Rating) - Analysts at HC Wainwright reduced their Q2 2023 earnings per share estimates for Alpha Tau Medical in a report released on Wednesday, May 24th. HC Wainwright analyst Y. Chen now expects that the company will earn ($0.12) per share for the quarte